Global Human Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023-中商产业研究院

内容概括

According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. Scope of the Report:
This report focuses on the Human Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
A major trend being witnessed in the global human vaccines market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.
The growth of the global human vaccines market is driven by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines. Similarly, the increase in the prevalence of infectious diseases and cancers is also leading to market growth.
The worldwide market for Human Vaccine is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 24600 million US$ in 2023, from 14100 million US$ in 2017, according to a new GIR (Global Info Research) study.Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Bavarian Nordic
Baxter
Bharat BiotechMarket Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Conjugate
Recombinant
Inactivated
Combination
Attenuated
OthersMarket Segment by Applications, can be divided into
Pediatrics
Adolescents
Adults
GeriatricsThere are 15 Chapters to deeply display the global Human Vaccine market.
Chapter 1, to describe Human Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Vaccine, with sales, revenue, and price of Human Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

报告目录

1 Market Overview

1.1 Human Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Conjugate

1.2.2 Recombinant

1.2.3 Inactivated

1.2.4 Combination

1.2.5 Attenuated

1.2.6 Others

1.3 Market Analysis by Applications

1.3.1 Pediatrics

1.3.2 Adolescents

1.3.3 Adults

1.3.4 Geriatrics

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.4 South America, Middle East and Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GlaxoSmithKline

2.1.1 Business Overview

2.1.2 Human Vaccine Type and Applications

2.1.3 GlaxoSmithKline Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Human Vaccine Type and Applications

2.2.3 Merck Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Human Vaccine Type and Applications

2.3.3 Pfizer Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Human Vaccine Type and Applications

2.4.3 Sanofi Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Human Vaccine Type and Applications

2.5.3 AstraZeneca Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bavarian Nordic

2.6.1 Business Overview

2.6.2 Human Vaccine Type and Applications

2.6.3 Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Baxter

2.7.1 Business Overview

2.7.2 Human Vaccine Type and Applications

2.7.3 Baxter Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bharat Biotech

2.8.1 Business Overview

2.8.2 Human Vaccine Type and Applications

2.8.3 Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Human Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Vaccine Market Analysis by Regions

4.1 Global Human Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Human Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Human Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Human Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Vaccine Sales and Growth Rate (2013-2018)

5 North America Human Vaccine by Countries

5.1 North America Human Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Human Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Human Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Human Vaccine Sales and Growth Rate (2013-2018)

6 Europe Human Vaccine by Countries

6.1 Europe Human Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Human Vaccine Sales and Growth Rate (2013-2018)

6.4 France Human Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Human Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Human Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Vaccine by Countries

7.1 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Human Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Human Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Human Vaccine Sales and Growth Rate (2013-2018)

7.5 India Human Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Vaccine Sales and Growth Rate (2013-2018)

8 South America Human Vaccine by Countries

8.1 South America Human Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Human Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Human Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Human Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Vaccine by Countries

9.1 Middle East and Africa Human Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Human Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Human Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Human Vaccine Sales and Growth Rate (2013-2018)

10 Global Human Vaccine Market Segment by Type

10.1 Global Human Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Conjugate Sales Growth and Price

10.2.1 Global Conjugate Sales Growth (2013-2018)

10.2.2 Global Conjugate Price (2013-2018)

10.3 Recombinant Sales Growth and Price

10.3.1 Global Recombinant Sales Growth (2013-2018)

10.3.2 Global Recombinant Price (2013-2018)

10.4 Inactivated Sales Growth and Price

10.4.1 Global Inactivated Sales Growth (2013-2018)

10.4.2 Global Inactivated Price (2013-2018)

10.5 Combination Sales Growth and Price

10.5.1 Global Combination Sales Growth (2013-2018)

10.5.2 Global Combination Price (2013-2018)

10.6 Attenuated Sales Growth and Price

10.6.1 Global Attenuated Sales Growth (2013-2018)

10.6.2 Global Attenuated Price (2013-2018)

10.7 Others Sales Growth and Price

10.7.1 Global Others Sales Growth (2013-2018)

10.7.2 Global Others Price (2013-2018)

11 Global Human Vaccine Market Segment by Application

11.1 Global Human Vaccine Sales Market Share by Application (2013-2018)

11.2 Pediatrics Sales Growth (2013-2018)

11.3 Adolescents Sales Growth (2013-2018)

11.4 Adults Sales Growth (2013-2018)

11.5 Geriatrics Sales Growth (2013-2018)

12 Human Vaccine Market Forecast (2018-2023)

12.1 Global Human Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Human Vaccine Market Forecast (2018-2023)

12.2.2 Europe Human Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Vaccine Market Forecast (2018-2023)

12.2.4 South America Human Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Vaccine Market Forecast (2018-2023)

12.3 Human Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Human Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Human Vaccine Market Share Forecast by Type (2018-2023)

12.4 Human Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Human Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Human Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

版权声明

本报告所有内容受法律保护，中华人民共和国涉外调查许可证：国统涉外证字第1454号。本报告由中商产业研究院出品，报告版权归中商产业研究院所有。本报告是中商产业研究院的研究与统计成果，报告为有偿提供给购买报告的客户内部使用。未获得中商产业研究院书面授权，任何网站或媒体不得转载或引用，否则中商产业研究院有权依法追究其法律责任。如需订阅研究报告，请直接联系本网站，以便获得全程优质完善服务。本报告目录与内容系中商产业研究院原创，未经本公司事先书面许可，拒绝任何方式复制、转载。在此，我们诚意向您推荐鉴别咨询公司实力的主要方法。